Dyslipidemia
Conditions
Interventions
Administration of placebo twice daily for 8 weeks
Administration of Palmaria palmata (2g/day) twice daily for 8 weeks
Sponsors
Hokkaido University Graduate School
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1)Participants who are 20-year-old or older, and younger than 60-year-old at the time of obtaining informed consent 2)Participants whose fasting serum LDL colesterol levels are more than 120 mg/dL 3)Participants who can visit the medical institution according to schedule 4)Participants who are able to understand the study and willing to provide written informed consent
Exclusion criteria
Exclusion criteria: 1)Participants whose fasting serum triglyceride levels are more than 400 mg/dL 2)Participants in pregnancy, lactation and scheduled pregnancy period 3)Participants who have made a blood donation within 2 (component blood donation), 4 (200mL), or 12 (400mL) weeks 4)Participants who are attending other studies or attended other studies within past 4 weeks 5)Participants with present heart, liver, kidney or thyroid disorders 6)Participants with a history of cardiac disorder 7)Participants with diabetes 8)Participants with allergy to the study foods 9)Participants who have been felt ill by blood collection 10)Participants with heavy use of alcohol 11)Participants with heavy smoking 12)Participants with irregular eating habits 13)Participants who are taking drugs, foods for specified health use or functional foods which could affect this study 14)Participants with a history of receiving a gastrointestinal surgery 15)Participants who are deemed to be unsuitable by the investigator
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| LDL cholesterol | — |
Countries
Japan
Contacts
Public ContactAkinobu Nakamura
Hokkaido University Graduate School Department of Rheumatology, Endocrinology and Nephrology
Outcome results
None listed